{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:48:16Z","timestamp":1792090096228,"version":"4.4.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1005277","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000}}],"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National High-Level Talent Special Support Programs-Leading Talent in Scientific and Technological Innovation"},{"name":"High-Level Public Health Talents","award":["xuekegugan-02-47"],"award-info":[{"award-number":["xuekegugan-02-47"]}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Amlodipine and nifedipine are the most commonly prescribed calcium channel blockers (CCB) for patients suffering from ischemic stroke or transient ischemic attack (TIA). Nevertheless, there is a scarcity of direct comparative evidence on their effectiveness. This study aimed to compare the effectiveness of amlodipine and nifedipine in patients with ischemic stroke or TIA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      This observational study was based on the Third China National Stroke Registry, which recruited consecutive adult patients with ischemic stroke or TIA from 2015 to 2018. In this study, ischemic stroke or TIA patients were prescribed either amlodipine or nifedipine at discharge. The primary outcome was the distribution of modified Rankin Scale (mRS) score, which assesses functional outcomes in patients with stroke, at 5 years. The intergroup differences were examined using ordinal logistic regression, yielding odds ratios (OR) and 95% confidence intervals (CI). Patient age, gender, body mass index, systolic blood pressure at admission, and onset date were adjusted. To improve baseline characteristic balance, inverse probability of treatment weighting (IPTW) was implemented. A total of 2,859 eligible patients were included, and there were 1847 patients in the amlodipine group and 1,058 patients in the nifedipine group after IPTW. The amlodipine group demonstrated significantly lower 5-year mRS scores in comparison to the nifedipine group, with an OR of 0.76 (95% CI [0.65, 0.89];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). A total of 956 (51.76%) amlodipine users and 632 (59.74%) nifedipine users achieved a mRS score\u2009&gt;\u20090 at 5 years, with an OR of 0.71 (95% CI [0.61, 0.83];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The sensitivity analyses yielded consistent results. The main limitations include the inherent observational design, the exclusive reliance on registry data, and relatively high loss-to-follow-up rate at 5 years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study revealed that amlodipine, compared to nifedipine, may be associated with improved functional recovery in ischemic stroke or TIA patients. Randomized controlled trials are warranted to confirm these findings and refine CCB therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1005277","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:33:11Z","timestamp":1791826391000},"page":"e1005277","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness of amlodipine versus nifedipine prescribed at discharge in patients with ischemic stroke or transient ischemic attack: A nationwide 5-year follow-up registry study"],"prefix":"10.1371","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7539-8194","authenticated-orcid":true,"given":"Xinya","family":"Li","sequence":"first","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Neurology, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Clinical Epidemiology and Clinical Trial"]},{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University","place":["Beijing, China"],"department":["Department of Epidemiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1719-0598","authenticated-orcid":true,"given":"Xue","family":"Xia","sequence":"additional","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Neurology, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Clinical Epidemiology and Clinical Trial"]},{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University","place":["Beijing, China"],"department":["Department of Epidemiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9384-328X","authenticated-orcid":true,"given":"Meng","family":"Gao","sequence":"additional","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Neurology, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Clinical Epidemiology and Clinical Trial"]},{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University","place":["Beijing, China"],"department":["Department of Epidemiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-709X","authenticated-orcid":true,"given":"Qin","family":"Xu","sequence":"additional","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Neurology, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Clinical Epidemiology and Clinical Trial"]},{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University","place":["Beijing, China"],"department":["Department of Epidemiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Neurology, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Clinical Epidemiology and Clinical Trial"]},{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University","place":["Beijing, China"],"department":["Department of Epidemiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9822-5758","authenticated-orcid":true,"given":"Jing","family":"Jing","sequence":"additional","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhai","sequence":"additional","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Neurology, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Clinical Epidemiology and Clinical Trial"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4351-2877","authenticated-orcid":true,"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Neurology, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital"]},{"name":"Capital Medical University","place":["Beijing, China"],"department":["Department of Clinical Epidemiology and Clinical Trial"]},{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University","place":["Beijing, China"],"department":["Department of Epidemiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"10446","key":"pmed.1005277.ref001","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","article-title":"Stroke","volume":"403","author":"NA Hilkens","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"pmed.1005277.ref002","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"GBD 2021 Stroke Risk Factor Collaborators.","year":"2024","journal-title":"Lancet Neurol"},{"issue":"4","key":"pmed.1005277.ref003","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.2020.25071","article-title":"Incidence of transient ischemic attack and association with long-term risk of stroke","volume":"325","author":"V-A Lioutas","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"pmed.1005277.ref004","article-title":"Diagnosis, workup, risk reduction of transient ischemic attack in the emergency department setting: a scientific statement from the American Heart Association","volume":"54","author":"HP Amin","year":"2023","journal-title":"Stroke"},{"issue":"7","key":"pmed.1005277.ref005","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/17474930241267353","article-title":"Hyperacute ischemic stroke care-Current treatment and future directions","volume":"19","author":"BC Campbell","year":"2024","journal-title":"Int J Stroke"},{"issue":"9523","key":"pmed.1005277.ref006","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"ESPRIT Study Group","year":"2006","journal-title":"Lancet"},{"issue":"10385","key":"pmed.1005277.ref007","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(23)00575-5","article-title":"Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial","volume":"401","author":"SGH Olthuis","year":"2023","journal-title":"Lancet"},{"key":"pmed.1005277.ref008","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012796","article-title":"Thrombus composition, imaging, and outcome prediction in acute ischemic stroke","volume":"97","author":"RA Joundi","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"pmed.1005277.ref009","doi-asserted-by":"crossref","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"DO Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"pmed.1005277.ref010","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","author":"DW Jones","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"pmed.1005277.ref011","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jch.13543","article-title":"A randomized controlled trial on the blood pressure-lowering effect of amlodipine and nifedipine-GITS in sustained hypertension","volume":"21","author":"Q-F Huang","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"13","key":"pmed.1005277.ref012","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318230201a","article-title":"Short-acting nifedipine and risk of stroke in elderly hypertensive patients","volume":"77","author":"S-Y Jung","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"pmed.1005277.ref013","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/svn-2019-000242","article-title":"The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics","volume":"4","author":"Y Wang","year":"2019","journal-title":"Stroke Vasc Neurol"},{"issue":"11","key":"pmed.1005277.ref014","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.2020.26867","article-title":"Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review","volume":"325","author":"SJ Mendelson","year":"2021","journal-title":"Jama"},{"issue":"10","key":"pmed.1005277.ref015","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.20.10.1407","article-title":"Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders","volume":"20","author":"Stroke","year":"1989","journal-title":"Stroke"},{"issue":"9","key":"pmed.1005277.ref016","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1161\/STROKEAHA.121.034480","article-title":"Standardized nomenclature for modified Rankin scale global disability outcomes: consensus recommendations from stroke therapy academic industry roundtable XI","volume":"52","author":"JL Saver","year":"2021","journal-title":"Stroke"},{"issue":"4","key":"pmed.1005277.ref017","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-Value","volume":"167","author":"TJ VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"6","key":"pmed.1005277.ref018","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/cpdd.1064","article-title":"Pharmacokinetics, bioequivalence, and safety studies of amlodipine besylate in healthy subjects","volume":"11","author":"B Chen","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"9","key":"pmed.1005277.ref019","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/pharmaceutics17091235","article-title":"Development and evaluation of a modified fixed-dose combination antihypertensive tablet containing S-amlodipine besylate: a bioequivalence and stability study","volume":"17","author":"HW Moon","year":"2025","journal-title":"Pharmaceutics"},{"key":"pmed.1005277.ref020","doi-asserted-by":"crossref","first-page":"110755","DOI":"10.1016\/j.intimp.2023.110755","article-title":"Therapeutic improvements of nifedipine controlled-release tablets combined with sacubitril valsartan on patients with diabetic nephropathy complicated with hypertension","volume":"123","author":"Y Wei","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"pmed.1005277.ref021","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cpdd.1396","article-title":"Comparative bioequivalence and food effect of two formulations of 30-mg nifedipine controlled-release tablets in healthy Chinese adults","volume":"13","author":"H Zhang","year":"2024","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"13","key":"pmed.1005277.ref022","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/eurheartj\/ehad814","article-title":"Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial","volume":"45","author":"A Gupta","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"pmed.1005277.ref023","doi-asserted-by":"crossref","DOI":"10.1111\/jch.70160","article-title":"Systolic blood pressure time in the target range and blood pressure variability: the effects of amlodipine-based therapy","volume":"27","author":"L Zhao","year":"2025","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"13","key":"pmed.1005277.ref024","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.102.13.1503","article-title":"Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators","volume":"102","author":"B Pitt","year":"2000","journal-title":"Circulation"},{"issue":"9489","key":"pmed.1005277.ref025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"B Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"pmed.1005277.ref026","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/joim.13170","article-title":"Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study","volume":"289","author":"I Kalar","year":"2021","journal-title":"J Intern Med"},{"issue":"1","key":"pmed.1005277.ref027","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41420-025-02784-3","article-title":"Amlodipine exerts inhibitory effects against glioma stem cells through degrading EGFR and down-regulating its downstream pro-survival pathways","volume":"11","author":"Z Li","year":"2025","journal-title":"Cell Death Discov"},{"issue":"1","key":"pmed.1005277.ref028","doi-asserted-by":"crossref","first-page":"33277","DOI":"10.1038\/s41598-025-18925-8","article-title":"In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine","volume":"15","author":"K Da\u0144kowska","year":"2025","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1005277","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:53:13Z","timestamp":1792086793000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005277"}},"subtitle":[],"editor":[{"given":"Joshua Z","family":"Willey","sequence":"first","affiliation":[{"name":"Columbia University","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1005277","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]}}}